Cover Image

Expression Distribution of Cancer Stem Cells, Epithelial to Mesenchymal Transition, and Telomerase Activity in Breast Cancer and Their Association with Clinicopathologic Characteristics

Show other versions (1)

A total of 167 surgically resected primary invasive breast carcinomas and 63 metastatic lymph node lesions were analyzed for immunohistochemical (IHC) localization of the CD44 + CD24 _low breast cancer stem cell (CSC) markers, epithelial to mesenchymal transition (EMT) markers, and telomerase activi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jaafar Makki (Author), Ohnmar Myint (Author), Aye Aye Wynn (Author), Ahmad Toha Samsudin (Author), John Daisy Vanitha (Author)
Format:	Book
Published:	SAGE Publishing, 2015-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Expression Distribution of Cancer Stem Cells, Epithelial to Mesenchymal Transition, and Telomerase Activity in Breast Cancer and Their Association with Clinicopathologic Characteristics
by: Jaafar Makki, et al.
Published: (2015)

The Epithelial-to-Mesenchymal Transition (EMT) in Cancer
by: Joëlle Roche (Ed.)
Published: (2018)

Epithelial-mesenchymal transition and stem cells in colorectal cancer progression
by: M. A. Shyshkin, et al.
Published: (2020)

Clinical impact of epithelial-mesenchymal transition for cancer therapy
by: Nobendu Mukerjee, et al.
Published: (2024)

Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer
by: Bo Dong, et al.
Published: (2020)

Colocynth Extracts Prevent Epithelial to Mesenchymal Transition and Stemness of Breast Cancer Cells
by: Kaushik Chowdhury, et al.
Published: (2017)

The Mechanism and Dynamic Regulation of Epithelial to Mesenchymal Transition in Ovarian Cancer
by: Pande Kadek Aditya Prayudi, et al.
Published: (2023)

Exploring the Crosstalk between Inflammation and Epithelial-Mesenchymal Transition in Cancer
by: Indranil Chattopadhyay, et al.
Published: (2021)

Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells
by: Sanya Haiaty, et al.
Published: (2021)

MicroRNA-140 Inhibits the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer
by: Jiazhi Li, et al.
Published: (2018)

Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer
by: Hui-Wen Yang, et al.
Published: (2023)

Maelstrom promotes tumor metastasis through regulation of FGFR4 and epithelial-mesenchymal transition in epithelial ovarian cancer
by: Wei-Peng He, et al.
Published: (2022)

Epithelial-to-mesenchymal transition in the development of adenomyosis
by: Ben-Shian Huang, et al.
Published: (2015)

Vitamin D and the Epithelial to Mesenchymal Transition
by: María Jesús Larriba, et al.
Published: (2016)

Telomerase: An exploration toward the end of cancer
by: Deepika Bablani Popli, et al.
Published: (2017)

Treating Cancer by Targeting Telomeres and Telomerase
by: Marko Ivancich, et al.
Published: (2017)

Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells
by: Wang YY, et al.
Published: (2015)

Correction to: Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells
by: Sanya Haiaty, et al.
Published: (2021)

Corrigendum: Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer
by: Hui-Wen Yang, et al.
Published: (2024)

Aberrant Expression of Epithelial-Mesenchymal Transition Markers in Early Gastric Cancer: Clinical Application
by: Moon Kyung Joo
Published: (2019)

Clinicopathological of Pre-Operative Thrombocytosis in Epithelial Ovarian Cancer
by: Catherine Sugandi, et al.
Published: (2024)

Immunohistochemical Expression of Epithelial-Mesenchymal Transition Markers in Early Gastric Cancer: Cancer Tissue versus Noncancer Tissue
by: Hee Jae Jung, et al.
Published: (2019)

The Association Between Inflammation, Epithelial Mesenchymal Transition and Stemness in Colorectal Carcinoma
by: Briede I, et al.
Published: (2020)

Retraction Notice to: MicroRNA-140 Inhibits the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer
by: Jiazhi Li, et al.
Published: (2022)

Targeting BMI-1-mediated epithelial-mesenchymal transition to inhibit colorectal cancer liver metastasis
by: Zhiyao Xu, et al.
Published: (2021)

The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer
by: S. N. Gancedo, et al.
Published: (2024)

The prognostic marker elastin correlates with epithelial-mesenchymal transition and vimentin‐positive fibroblasts in gastric cancer
by: Tianyi Fang, et al.
Published: (2023)

Topotecan inhibits metastasis of non-small cell lung cancer by regulating epithelial-mesenchymal transition
by: Zhen Liu, et al.
Published: (2022)

Epithelial-mesenchymal transition: Understanding the basic concept
by: Suresh Babu Ghanta, et al.
Published: (2012)

Noncoding RNAs in Tumor Epithelial-to-Mesenchymal Transition
by: Ching-Wen Lin, et al.
Published: (2016)

Long non-coding RNA AOC4P suppresses epithelial ovarian cancer metastasis by regulating epithelial-mesenchymal transition
by: Xiaojing Lin, et al.
Published: (2020)

Identification of molecular patterns and prognostic models of epithelial-mesenchymal transition- and immune-combined index in the gastric cancer
by: Xiuyuan Zhang, et al.
Published: (2022)

miR-200c regulation of metastases in ovarian cancer: Potential role in epithelial and mesenchymal transition
by: Siti Aishah Sulaiman, et al.
Published: (2016)

Precision treatment paradigm: Genomic features and therapeutic implications in mesenchymal‐epithelial transition‐amplified gastric cancer
by: Yiyi Yu, et al.
Published: (2024)

Non-invasive detection of epithelial mesenchymal transition phenotype and metastatic dissemination of lung cancer by liquid biopsy
by: Viviana De Rosa, et al.
Published: (2021)

Reversing an Oncogenic Epithelial-to-Mesenchymal Transition Program in Breast Cancer Reveals Actionable Immune Suppressive Pathways
by: Michelle M. Williams, et al.
Published: (2021)

Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells
by: Ding YH, et al.
Published: (2015)

Natural Plants Compounds as Modulators of Epithelial-to-Mesenchymal Transition
by: Lorena Avila-Carrasco, et al.
Published: (2019)

Epithelial-to-Mesenchymal Transition in Fibrosis: Concepts and Targeting Strategies
by: Sara Lovisa, et al.
Published: (2021)

Tempol effect on epithelial-mesenchymal transition induced by hyperglycemia
by: Mohammad Jafari, et al.
Published: (2017)